AMANDA MCCANN: Open Payments
NPI 1225436488 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 77 payments from 14 companies in 2025. Trend: 2023 $1,161 · 2024 $1,534 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $404 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $223 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Novo Nordisk Inc | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| PFIZER INC. | 3 | $50 |
| United Therapeutics Corporation | 2 | $49 |
| Amgen Inc. | 3 | $48 |
Products named: LEQVIO, LifeVest, Kerendia, Wegovy, AMVUTTRA, JARDIANCE, WINREVAIR, VERQUVO.
Industry payments across AL — which companies pay providers there.
